Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie

Lung Cancer. 2013 Dec;82(3):510-1. doi: 10.1016/j.lungcan.2013.09.006. Epub 2013 Sep 21.

Authors

M Evans¹, Y Summers, P Taylor, M Harris, N Bayman, C Faivre-Finn, H Sheikh, P Burt, F Blackhall, R Califano

Affiliation

¹ Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

PMID: 24138902
DOI: 10.1016/j.lungcan.2013.09.006

No abstract available

Keywords: Adenocarcinoma; EGFR activating mutations; Mutation analysis; Non-small cell lung cancer.

Publication types

Letter

MeSH terms

Aged
Carcinoma, Non-Small-Cell Lung / diagnosis*
Carcinoma, Non-Small-Cell Lung / genetics
DNA Mutational Analysis
Early Detection of Cancer
Female
Genes, erbB-1 / genetics*
Humans
Interdisciplinary Communication
Lung Neoplasms / diagnosis*
Lung Neoplasms / genetics
Male
Medical Oncology
Mutation / genetics*
Neoplasm Staging
Pilot Projects
Referral and Consultation
Time Factors
United Kingdom